Brief: Xbrane Re-Negotiates Pre-Existing IP License Agreement With Vaxiion Therapeutics

Xbrane Biopharma AB

05/01/2021 07:42

Jan 5 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * XBRANE RE-NEGOTIATES PRE-EXISTING IP LICENSE AGREEMENT
WITH
VAXIION THERAPEUTICS
    * RE-NEGOTIATED A PRE-EXISTING LICENSE AGREEMENT OF CERTAIN
INTELLECTUAL PROPERTY RIGHTS, MAINLY PATENT US7871815B2, WITH
VAXIION THERAPEUTICS
    * RE-NEGOTIATED LICENSE AGREEMENT GIVES XBRANE FULL
NON-EXCLUSIVE
RIGHTS TO MENTIONED IP
    * RE-NEGOTIATED LICENSE AGREEMENT ENTITLES VAXIION TO A LOW
SINGLE
DIGIT MILLION SEK UPFRONT PAYMENT AS WELL AS LOW SINGLE DIGIT
ROYALTIES ON SALES INCOME GENERATED BY XBRANE FROM
PHARMACEUTICAL PRODUCTS PRODUCED LEVERAGING IP, THROUGH FEBRUARY
2024
    * AFTER FEB 2024 XBRANE CAN CONTINUE TO UTILIZE VAXIION IP
FOR ALL
ITS PRODUCTS WITHOUT ANY FURTHER ROYALTY PAYMENTS TO VAXIION.

Source text for Eikon:  ID:nMFN9RY8cz 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))